Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rijken

Showing results (101-110 of 810) with videos related to

Pageof 81
Sort By:
Physics in Medicine and Biology|October 1, 2019
Linear accelerator bunker shielding for stereotactic radiotherapyJames Rijken, Madhava Bhat, Scott Crowe, et al.
Journal of Intellectual Disability Research : JIDR|September 30, 2011
People with mild to moderate intellectual disability talking about their diabetes and how they manageM Cardol, M Rijken, H van Schrojenstein Lantman-de Valk
The British Journal of Radiology|January 9, 2007
Computer aided detection of masses in mammograms as decision supportN Karssemeijer, J D M Otten, H Rijken, et al.
Journal of Health Psychology|August 25, 2010
The development of and first experiences with a behavioural self-regulation intervention for end-stage renal disease patients and their partnersDaphne L Jansen, Monique Heijmans, Mieke Rijken, et al.
Journal of Health Organization and Management|March 5, 2015
People with multimorbidity: forgotten outsiders or dynamic self-managers?Anneli Hujala, Mieke Rijken, Sanna Laulainen, et al.
Journal of Applied Clinical Medical Physics|March 19, 2019
Distributive quality assurance and delivery of stereotactic ablative radiotherapy treatments amongst beam matched linear accelerators: A feasibility studyJames Rijken, Hilmar Schachenmayr, Scott Crowe, et al.
The Journal of Biological Chemistry|March 25, 1982
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrinM Hoylaerts, D C Rijken, H R Lijnen, et al.
Journal of Medical Imaging and Radiation Oncology|October 8, 2014
Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: a retrospective studySolveig Grenfell, Daniel Roos, James Rijken, et al.
Journal of Applied Clinical Medical Physics|June 27, 2018
Improving accuracy for stereotactic body radiotherapy treatments of spinal metastasesJames Rijken, Barry Jordan, Scott Crowe, et al.
Thrombosis and Haemostasis|December 27, 1982
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivoD Collen, D C Rijken, J Van Damme, et al.
Pageof 81

Showing results (101-110 of 810) with videos related to

Sort By:
Pageof 81
Physics in Medicine and Biology|October 1, 2019
Linear accelerator bunker shielding for stereotactic radiotherapyJames Rijken, Madhava Bhat, Scott Crowe, et al.
Journal of Intellectual Disability Research : JIDR|September 30, 2011
People with mild to moderate intellectual disability talking about their diabetes and how they manageM Cardol, M Rijken, H van Schrojenstein Lantman-de Valk
The British Journal of Radiology|January 9, 2007
Computer aided detection of masses in mammograms as decision supportN Karssemeijer, J D M Otten, H Rijken, et al.
Journal of Health Psychology|August 25, 2010
The development of and first experiences with a behavioural self-regulation intervention for end-stage renal disease patients and their partnersDaphne L Jansen, Monique Heijmans, Mieke Rijken, et al.
Journal of Health Organization and Management|March 5, 2015
People with multimorbidity: forgotten outsiders or dynamic self-managers?Anneli Hujala, Mieke Rijken, Sanna Laulainen, et al.
Journal of Applied Clinical Medical Physics|March 19, 2019
Distributive quality assurance and delivery of stereotactic ablative radiotherapy treatments amongst beam matched linear accelerators: A feasibility studyJames Rijken, Hilmar Schachenmayr, Scott Crowe, et al.
The Journal of Biological Chemistry|March 25, 1982
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrinM Hoylaerts, D C Rijken, H R Lijnen, et al.
Journal of Medical Imaging and Radiation Oncology|October 8, 2014
Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: a retrospective studySolveig Grenfell, Daniel Roos, James Rijken, et al.
Journal of Applied Clinical Medical Physics|June 27, 2018
Improving accuracy for stereotactic body radiotherapy treatments of spinal metastasesJames Rijken, Barry Jordan, Scott Crowe, et al.
Thrombosis and Haemostasis|December 27, 1982
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivoD Collen, D C Rijken, J Van Damme, et al.
Pageof 81